
The nucleotide changes within HBV core promoter/precore during the first 12Â weeks of nucleos(t)ide treatment might be associated with a better virological response
Keywords: ADV; adefovir dipivoxil; BCP; basic core promoter; CHB; chronic hepatitis B; CP; core promoter; EN II; enhancer II; HBeAg; hepatitis e antigen; HBsAg; hepatitis B surface antigen; HBV; hepatitis B virus; LMV; lamivudine; Mut; mutation; NUC; nucleoside/nuc